3692 — Hansoh Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for Hansoh Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	13,718	18,933	21,623	24,857	23,386
Net Total Accounts Receivable
Net Total Receivables	3,210	3,782	3,674	3,321	3,170
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17,286	23,179	25,832	28,883	27,442
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,468	3,569	3,483	3,294	3,268
Net Intangible Assets
Long Term Investments
Total Assets	20,792	27,160	30,002	33,039	31,658
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,690	3,024	2,620	6,863	2,695
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	2,916	7,131	7,355	7,244	2,978
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	17,876	20,029	22,647	25,795	28,680
Total Liabilities & Shareholders' Equity	20,792	27,160	30,002	33,039	31,658
Total Common Shares Outstanding